Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTEND: Alteplase for Acute Ischemic Stroke 3-9 Hours Post Onset
NCT00887328Phase 3Completed
- Sponsor
- Neuroscience Trials Australia
- Start
- Jun 2010
- Primary completion
- Aug 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 3
01
Overview
A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Neuroscience Trials Australia. Started Jun 2010; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00887328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887328.